კი მაიკო

ქალბატონო თამარ, ეს რომ მივწერო ბრიტანეთს ვაქცინაციაზე მისაღებია?

Dear Clare,

Upon you request we would like to kindly inform you that vaccination could be provided to the Embassy staff in one of the hospitals located in Tbilisi:

1.      „Evex Hospitals“ (Ivane Bokeria Tbilisi Referral Hospital) #1 Kindzmarauli Turn, Tbilisi

2.      "Caucasusu Medical Center" #23 Petre Kavtaradze str., Tbilisi

3.      "Amtel Hospital First Clinical" #9 Tsinandali Str., Tbilisi

4.      “Infectious Diseases, AIDS and Clinical Immunology Research Center”, #16 Al. Kazbegi Ave., #29 Vazha Pshavela Ave., Tbilisi

5.      "N. Kipshidze Central University Clinic of Tbilisi State Medical University", #29 Vazha Pshavela Ave., Tbilisi

6.      “Iashvili Children’s Central Hospital”, Tbilisi, 13/6 Ljubljana Str. Tbilisi

As for the import permit, pursuant to the Order #327/N of the Minister of Labour, Health and Social Affairs of Georgia embassy should submit:

·         Application addressed to Mrs. Tamar Gabunia, First Deputy Minister of IDPs, Labour, Health and Social Affairs of Georgia and copy to Mr. Zaal Kapanadze, Director of the LEPL Regulation Agency for Medical and Pharmaceutical Activities (application should include information about the purpose of the vaccine delivery, name/amount of the vaccine and etc.) ;  

·         Certificate of Quality/Certificate of conformity (approval that delivered batch has been manufactured and tested in full compliance with GMP and in line with the requirements of the WHO Market Authorization);

·         Information pack/description of the product;

·         Certificate of analysis for designated batch of the product along with shipping documents (Air Waybill, Invoice, Packing list).

Please, inform us the date of vaccine delivery. We kindly advise you to submit the requested documents before the delivery of the goods in order to timely obtain the import permit.  

And, please note, that after designating one of the hospitals for vaccination, the list of the Embassy staff/family members should be provided to the health facility for registration purposes.

We remain at your disposal for further collaboration and support.

Best regards,

Maia Nikoleishvili MPA

Head of International Relations and Protocol Division of Administration

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail: mnikoleishvili@moh.gov.ge

Dear Maia,

Thank you very much for your telephone call earlier. I am very grateful for the Deputy Minister having introduced you to me.

As I explained on the telephone, the UK’s foreign ministry - the Foreign, Commonwealth and Development Office (FDCO) - intends to make Covid-19 vaccines available to its staff serving overseas, as part of the UK’s national vaccination programme. A small proportion of staff may return to the UK for vaccination. But the vast majority of staff will be vaccinated through delivery of vaccine doses to overseas missions, where a local medical provider contacted by the mission will administer the vaccine. This is the approach that will be used for our embassy in Georgia.

It will be the Oxford University/AstraZeneca vaccine used by the FCDO for this purpose. It will be dispatched from the UK, where is has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), one of the internationally-recognised stringent regulatory authorities. The pharmaceutical specifications of the vaccine are at the bottom of this email. In the UK the supply of vaccines to medical providers is controlled by Public Health England (PHE), part of our ministry of health. It is from PHE directly that vaccine supplies are being sent to British embassies overseas.

As we discussed, I would be very grateful for your advice on the appropriate approval mechanisms

- for the Embassy to import the vaccine for its own use and  

- for a clinic in Georgia to store the vaccines on the Embassy’s behalf, and administer the vaccines to individual staff members  

From the UK side, there are several possible options for delivering the vaccines to Georgia, including a diplomat carrying them by hand, provided that did not cause any difficulty for the later administration of the vaccines. We will of course follow your advice on this.

The supply we will receive will be a batch of 80 doses. To vaccinate all our staff (and the adult family members of our diplomatic staff) we will need two batches. At this stage I do not know whether we will receive two batches in one delivery, or a first batch initially and a second batch later.

I said on the telephone that we had spoken to the American Medical Centre (AMC) in Tbilisi about the possibility of them storing and administering the vaccines for us, under a commercial contract with the Embassy. Our Embassy uses AMC for general medical procedures for our diplomatic staff, including standard vaccinations for children, so it is natural for us to consider this clinic. However we would be able to use any clinic that is authorised to store and administer Covid-19 vaccines under Georgian regulations, and willing to follow some guidelines on administration issued by Public Health England (PHE). I would be pleased to share these guidelines with you if it would help identify a possible doctor/clinic. AMC have been very clear that they can only assist us with prior approval for the vaccines from the Ministry of Health.   

Please let me know if you need any additional information from me at this stage. You are welcome to call me by telephone at any time too. I am very grateful for you kindly considering these questions on the Embassy’s behalf. I am sure we are not the only diplomatic mission in Tbilisi that is trying to import vaccines for staff.

Kind regards,

Clare

Clare Allbless | Deputy Head of Mission and HM Consul | Tbilisi

British Embassy | 51 Krtsanisi Street | Tbilisi 0114 | Georgia

M: +995 591 00 4436 | Clare.Allbless@fcdo.gov.uk

GOV.UK/FCDO | FCDO on YouTube | FCDO Flickr | FCDO on Facebook | FCDO on Twitter | @FCDO Careers

INFORMATION FOR HEALTHCARE PROFESSIONALS

1. NAME OF THE MEDICINAL PRODUCT

COVID-19 Vaccine AstraZeneca, solution for injection in multidose container

COVID-19 Vaccine (ChAdOx1-S [recombinant])

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

One dose (0.5 ml) contains:

COVID-19 Vaccine (ChAdOx1-S* recombinant) 5 × 1010 viral particles (vp)

*Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike (S) glycoprotein. Produced in genetically modified human embryonic kidney (HEK) 293 cells.

This product contains genetically modified organisms (GMOs). It does not contain preservatives.

3. PHARMACEUTICAL FORM

Solution for injection.

The solution is colourless to slightly brown, clear to slightly opaque and particle free with a pH of 6.6.

Follow us online: www.gov.uk/fcdo

This email is intended for the addressee(s) only.  All messages sent and received by the Foreign, Commonwealth & Development Office may be monitored in line with relevant UK legislation